Fertility patients and their prescriptions: a two-year audit of patient-pharmacist interactions in a reproductive endocrinology practice

Hdl Handle:
http://hdl.handle.net/10147/237477
Title:
Fertility patients and their prescriptions: a two-year audit of patient-pharmacist interactions in a reproductive endocrinology practice
Authors:
Sills, Eric S; Shurpyak, Serhiy A; Gorman, Deirdre J; Shkrobot, Lyuda V; Murray, Grainne U; O'Connor, Beppi MG; Rapple, Una E; Fogarty, Alicia O; Svarkova, Pavlina; Brickell, Kathy M; Walsh, David J
Citation:
International Archives of Medicine. 2009 Aug 03;2(1):24
Issue Date:
3-Aug-2009
URI:
http://dx.doi.org/10.1186/1755-7682-2-24; http://hdl.handle.net/10147/237477
Abstract:
Abstract Background This study assessed pharmacy performance and satisfaction as reported by patients during ovulation induction therapy. Materials and methods Patients (n = 1269) receiving gonadotropin prescriptions for intrauterine insemination or in vitro fertilisation-embryo transfer in 2007–2008 were prospectively interviewed by nurses and/or completed a structured questionnaire to evaluate pharmacy performance. "Community" (n = 12) and "specialty" (n = 2) pharmacy status (C vs. S) was defined by each pharmacy, and all pharmacies were selected by patients before cycle start. Patient comments about their pharmacy were classified into five types: i) Dispensing error-gonadotropin, ii) Dispensing error-non gonadotropin, iii) Mistake in prescribed medical equipment/supplies, iv) Counselling/communication inaccuracy, and v) Inventory problem or other. Results 391 pharmacy concerns were reported from 150 fertility patients during the study period. The majority (75.9%) of patients selected a S pharmacy to fill their prescriptions, and this pharmacy type was identified in 2.8% of adverse pharmacy encounters (p < 0.0001). Non-gonadotropin prescriptions filled at C pharmacies accounted for 40.2% of all complaints, followed by problems with prescriptions for supplies (20.2%) and gonadotropins (18.7%) at C pharmacies. Patient conflict involving S pharmacies was limited (n = 11), and related to operating hours and medication delivery logistics. Conclusion Fertility patients reported a disproportionate and significantly higher number of adverse pharmacy encounters from C pharmacies compared to S pharmacies. Although no licensing mechanism in Ireland currently recognises special training or certification in any area of pharmacy practice, informal self-designations by pharmacies remain a useful discriminator. Level of familiarity with fertility medicines and availability of inventory are important characteristics to be considered when counselling fertility patients about pharmacy choice. Those who select a C pharmacy should be advised to allow extra time for inventory verification, order confirmation, and additional counselling. Additional study is needed to determine if a minimum volume of fertility-related prescriptions is necessary to assure competence in this particular field of pharmacy practice.
Item Type:
Journal Article

Full metadata record

DC FieldValue Language
dc.contributor.authorSills, Eric S-
dc.contributor.authorShurpyak, Serhiy A-
dc.contributor.authorGorman, Deirdre J-
dc.contributor.authorShkrobot, Lyuda V-
dc.contributor.authorMurray, Grainne U-
dc.contributor.authorO'Connor, Beppi MG-
dc.contributor.authorRapple, Una E-
dc.contributor.authorFogarty, Alicia O-
dc.contributor.authorSvarkova, Pavlina-
dc.contributor.authorBrickell, Kathy M-
dc.contributor.authorWalsh, David J-
dc.date.accessioned2012-08-07T09:18:54Z-
dc.date.available2012-08-07T09:18:54Z-
dc.date.issued2009-08-03-
dc.identifier.citationInternational Archives of Medicine. 2009 Aug 03;2(1):24-
dc.identifier.urihttp://dx.doi.org/10.1186/1755-7682-2-24-
dc.identifier.urihttp://hdl.handle.net/10147/237477-
dc.description.abstractAbstract Background This study assessed pharmacy performance and satisfaction as reported by patients during ovulation induction therapy. Materials and methods Patients (n = 1269) receiving gonadotropin prescriptions for intrauterine insemination or in vitro fertilisation-embryo transfer in 2007–2008 were prospectively interviewed by nurses and/or completed a structured questionnaire to evaluate pharmacy performance. "Community" (n = 12) and "specialty" (n = 2) pharmacy status (C vs. S) was defined by each pharmacy, and all pharmacies were selected by patients before cycle start. Patient comments about their pharmacy were classified into five types: i) Dispensing error-gonadotropin, ii) Dispensing error-non gonadotropin, iii) Mistake in prescribed medical equipment/supplies, iv) Counselling/communication inaccuracy, and v) Inventory problem or other. Results 391 pharmacy concerns were reported from 150 fertility patients during the study period. The majority (75.9%) of patients selected a S pharmacy to fill their prescriptions, and this pharmacy type was identified in 2.8% of adverse pharmacy encounters (p < 0.0001). Non-gonadotropin prescriptions filled at C pharmacies accounted for 40.2% of all complaints, followed by problems with prescriptions for supplies (20.2%) and gonadotropins (18.7%) at C pharmacies. Patient conflict involving S pharmacies was limited (n = 11), and related to operating hours and medication delivery logistics. Conclusion Fertility patients reported a disproportionate and significantly higher number of adverse pharmacy encounters from C pharmacies compared to S pharmacies. Although no licensing mechanism in Ireland currently recognises special training or certification in any area of pharmacy practice, informal self-designations by pharmacies remain a useful discriminator. Level of familiarity with fertility medicines and availability of inventory are important characteristics to be considered when counselling fertility patients about pharmacy choice. Those who select a C pharmacy should be advised to allow extra time for inventory verification, order confirmation, and additional counselling. Additional study is needed to determine if a minimum volume of fertility-related prescriptions is necessary to assure competence in this particular field of pharmacy practice.-
dc.titleFertility patients and their prescriptions: a two-year audit of patient-pharmacist interactions in a reproductive endocrinology practice-
dc.typeJournal Article-
dc.language.rfc3066en-
dc.rights.holderEric Sills et al.; licensee BioMed Central Ltd.-
dc.description.statusPeer Reviewed-
dc.date.updated2012-07-25T15:07:27Z-
All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.